Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.

Liver fibrosis results from the excessive secretion of matrix proteins by hepatic stellate cells (HSC), which proliferate during fibrotic liver injury. We have studied a model of spontaneous recovery from liver fibrosis to determine the biological mechanisms mediating resolution. Livers were harvested from rats at 0, 3, 7, and 28 d of spontaneous recovery from liver fibrosis induced by 4 wk of twice weekly intraperitoneal injections with CCl4. Hydroxyproline analysis and histology of liver sections indicated that the advanced septal fibrosis observed at time 0 (peak fibrosis) was remodeled over 28 d of recovery to levels close to control (untreated liver). alpha-Smooth muscle actin staining of liver sections demonstrated a 12-fold reduction in the number of activated HSC over the same time period with evidence of HSC apoptosis. Ribonuclease protection analysis of liver RNA extracted at each recovery time point demonstrated a rapid decrease in expression of the collagenase inhibitors TIMP-1 and TIMP-2, whereas collagenase mRNA expression remained at levels comparable to peak fibrosis. Collagenase activity in liver homogenates increased through recovery. We suggest that apoptosis of activated HSC may vitally contribute to resolution of fibrosis by acting as a mechanism for removing the cell population responsible for both producing fibrotic neomatrix and protecting this matrix from degradation via their production of TIMPs.

[1]  J. Iredale,et al.  Tissue inhibitor of metalloproteinase‐1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis , 1996, Hepatology.

[2]  G. Ramadori,et al.  CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. , 1997, The American journal of pathology.

[3]  J. Iredale,et al.  Tissue Inhibitor of Metalloproteinase-1 and Interstitial Collagenase Expression in Autoimmune Chronic Active Hepatitis and Activated Human Hepatic Lipocytes , 1995 .

[4]  S. Friedman,et al.  Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. , 1992, Journal of submicroscopic cytology and pathology.

[5]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[6]  H. Kawasaki,et al.  Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[7]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[8]  I. Bergman,et al.  Two Improved and Simplified Methods for the Spectrophotometric Determination of Hydroxyproline. , 1963 .

[9]  G. Evan,et al.  A License to Kill , 1996, Cell.

[10]  Y. Murawaki,et al.  Collagenase and collagenolytic cathepsin in normal and fibrotic rat liver. , 1990, Journal of biochemistry.

[11]  J. Hughes,et al.  Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. , 1994, The Journal of clinical investigation.

[12]  G. Gores,et al.  Apoptosis and hepatobiliary disease , 1995, Hepatology.

[13]  Pieter,et al.  Localization and cellular sources of activins in normal and fibrotic rat liver , 1997, Hepatology.

[14]  S. Friedman,et al.  Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. , 1989, The Journal of clinical investigation.

[15]  Cho-il Kim,et al.  Polyunsaturated lecithin prevents acetaldehyde‐mediated hepatic collagen accumulation by stimulating collagenase activity in cultured lipocytes , 1992, Hepatology.

[16]  G. Evan,et al.  Cooperative interaction between c-myc and bcl-2 proto-oncogenes , 1992, Nature.

[17]  K. Isselbacher,et al.  Lysyl oxidase and collagenase in experimental acute and chronic liver injury. , 1982, Gastroenterology.

[18]  D. Kershenobich,et al.  Hepatic Fibrosis , 1955, Gastroenterology.

[19]  S. Friedman.  The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies , 1993 .

[20]  R. Perez-Tamayo,et al.  Collagenase of hepatocytes and sinusoidal liver cells in the reversibility of experimental cirrhosis of the liver , 1990, Virchows Archiv. B, Cell pathology including molecular pathology.

[21]  J. Iredale,et al.  Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. , 1996, Gastroenterology.

[22]  G. Evan,et al.  Apoptosis and the cell cycle. , 1995, Current opinion in cell biology.

[23]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[24]  R. Perez-Tamayo,et al.  Collagenolytic activity in experimental cirrhosis of the liver. , 1987, Experimental and molecular pathology.

[25]  S. Saga,et al.  Clinical evaluation of serum tissue inhibitor of metalloproteinases‐1 levels in patients with liver diseases , 1993, Journal of gastroenterology and hepatology.

[26]  I. Okazaki,et al.  Collagenase activity in experimental hepatic fibrosis , 1974, Nature.

[27]  M. Arthur.  Matrix Degradation in the Liver , 1990, Seminars in liver disease.

[28]  H. Kawasaki,et al.  Serum collagenase activity in chronic liver diseases. , 1994, Pathology, research and practice.

[29]  H. Stein,et al.  Temporal and spatial patterns of transin/stromelysin RNA expression following toxic injury in rat liver , 1991, Virchows Archiv. B, Cell pathology including molecular pathology.

[30]  D. Vaux,et al.  The molecular biology of apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Friedman,et al.  Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. , 1992, The Journal of clinical investigation.

[32]  C. Lieber,et al.  Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis. , 1982, Life sciences.

[33]  M. Rissel,et al.  Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. , 1990, The American journal of pathology.

[34]  A. Burt.  Cellular and molecular aspects of hepatic fibrosis , 1993, The Journal of pathology.

[35]  C. López-Otín,et al.  Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. , 1994, The Journal of biological chemistry.